Nottingham University Hospitals NHS Trust, Queens Medical Centre Campus
Nottingham, Nottinghamshire, NG7 2UH, United Kingdom
NCT Number: NCT05995990
The aim of the proposed research is to develop a quick and reliable method for automated evaluation of tissue sections for residual tumour in histology specimens following liver surgery. This advanced technology will enable assessment of liver tumours and resection margins following liver surgery. The technology is based on Raman spectroscopy (RS) and multivariate spectral analysis to produce 2-dimensional biochemical images that can reliably separate the spectral signal of liver tumours from surrounding normal tissue.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Nottingham, Nottinghamshire, NG7 2UH, United Kingdom
In this proposal, investigators will investigate the ability of RS to distinguish between normal versus cancer in tissue blocks following liver surgery. If successful, this technique can then be investigated for intra-operative assessment efficacy to ensure that the resection margin of the tumour is clear (free of tumour cells), enabling this powerful procedure to be applied to all patients undergoing liver surgery for highest standard of care. This device is an early concept development of an In-Vitro Diagnostic Medical Device.
In this project investigators will answer the following two questions:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Laboratory technique of Raman Spectrometry
Time frame: 3 years
To determine whether Raman spectroscopy can discriminate between healthy liver tissue and liver tumours.
Time frame: 3 years
To determine how fast a Raman spectroscopy image of a tissue section can be built.
Nottingham University Hospitals NHS Trust
Other
Raman Spectral Imaging for Liver Tumours Following Liver Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03388190
Colorectal Cancer Metastatic, Neoplasm Metastasis
Bergen, Norway
View Trial DetailsNCT05625932
Cardiovascular Diseases, Colonic Diseases
Santiago de Compostela, A Coruña, Spain
View Trial DetailsNCT04874207
Colorectal Cancer Metastatic
Caen, France
View Trial DetailsNCT05480306
Colo-rectal Cancer, Colonic Diseases
Tucson, Arizona, United States
View Trial Details